| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Emily Fairbairn is Director at MOVE and has filed Form 4s across 2 companies. Emily Fairbairn's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.1M at current prices.
Historically, Emily Fairbairn's trades have earned a below-average insider score of 31/100 across 11 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -59.4%.
The biggest single holding is MOVE (~$8.1M) as Director. Net of sales, the MOVE filings show accumulation of 5,531,582 shares.
Emily Fairbairn has 36 Form 4 filings on record from March 2021 to July 2026, across 2 companies: Director at Movano (MOVE), 2021–2026; Director at IN8bio (INAB), 2021–2026.
The 51 reported transactions were 18 option or other derivative awards, 16 open-market purchases, 7 stock awards and 5 conversions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 8 purchases worth about $3.6M and no sales.
The largest open-market purchase was 789,473 shares of INAB at an average $1.90 on August 16, 2022, about $1.5M. Twelve months later INAB was down 37%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | MOVE Movano Inc. | Director | Buy | 4,690,000 | $0.00 | - | +1,590% | -39.3% | -80.0% | |
| Nov 14, 2023 | MOVE Movano Inc. | Director | Buy | 295,000 | $0.85 | $250,750.00 | New | -34.1% | -71.7% | |
| Jun 13, 2023 | MOVE Movano Inc. | Director | Buy | 250,000 | $1.00 | $250,000.00 | +89.7% | +8.0% | -59.1% | |
| Jan 27, 2023 | MOVE Movano Inc. | Director | Buy | 178,571 | $0.00 | - | +178.6% | -32.0% | -57.0% | |
| Aug 16, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 789,473 | $1.90 | $1,499,998.70 | +23.8% | -19.6% | -37.0% | |
| Apr 1, 2022 | MOVE Movano Inc. | Director | Buy | 8,011 | $2.80 | $22,461.46 | +2.0% | -14.6% | -56.1% | |
| Nov 23, 2021 | MOVE Movano Inc. | Director | Buy | 5,000 | $3.85 | $19,250.00 | +1.3% | -27.2% | -51.0% | |
| Nov 18, 2021 | MOVE Movano Inc. | Director | Buy | 5,000 | $3.97 | $19,870.00 | +1.3% | -27.6% | -54.5% | |
| Aug 3, 2021 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +3.1% | -22.2% | -75.4% | |
| Mar 23, 2021 | MOVE Movano Inc. | Director | Buy | 100,000 | $5.00 | $500,000.00 | New | -25.9% | -57.3% |